Finance

Lists
CANF:NYSEAMERICAN
Can Fite Biopharma ADR Representing 300 Ord Shs
$2.33
+7.87%
(+0.17) 1D
$2.33
0.00% (0.00)
After hours
Closed: Sep 11, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CANF...
Open
$2.17
High
$2.37
Low
$2.16
Mkt. cap
21.16M
Avg. vol.
729.24K
Volume
154.99K
52-wk high
$13.40
52-wk low
$2.16
Beta
1.12
Shares outstanding
3.03M
No. of employees
5
Open
$2.17
High
$2.37
Low
$2.16
Mkt. cap
21.16M
Avg. vol.
729.24K
Volume
154.99K
52-wk high
$13.40
52-wk low
$2.16
Beta
1.12
Shares outstanding
3.03M
No. of employees
5
News stories
From web sources and news partners
About Can Fite Biopharma ADR Representing 300 Ord Shs
CEO-
Employees5
Founded1994
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
101.50K
101.50K
101.00K
101.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.83M
1.83M
1.73M
1.73M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
798.00K
798.00K
713.00K
713.00K
Operating expense
2.63M
2.63M
2.44M
2.44M
Total operating expenses
2.63M
2.63M
2.44M
2.44M
Operating income
-2.53M
-2.53M
-2.34M
-2.34M
Other non operating income
-7.00K
-7.00K
-
-
EBT including unusual items
-2.48M
-2.48M
-2.30M
-2.30M
EBT excluding unusual items
-2.47M
-2.47M
-2.30M
-2.30M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.48M
-2.48M
-2.30M
-2.30M
Net profit margin
-2,439.41%
-2,439.41%
-2,277.72%
-2,277.72%
Earnings per share
-
-
-
-
Interest and investment income
131.00K
131.00K
39.50K
39.50K
Interest expense
-
-
-
-
Net interest expenses
131.00K
131.00K
39.50K
39.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.53M
-2.53M
-2.34M
-2.34M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps